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Increasing antibody resistance necessitates the use of new antimicrobial products. Antimicrobial peptides (AMP`s) And 
Proteins are a promising alternative to antibiotics currently being used due to their high degree of specificity & wide range 
of action Here we report a novel antimicrobial protein from iron reducing bacteria isolated from the coffee estate soils of 
Coorg district, Karnataka, India. Iron reducing bacteria are known to be antagonistic to others due to the presence of 
Pseuderophores. It makes them a good source of antimicrobial active principles. Fifteen isolates were obtained by 
selectively screening for iron reduction. These isolates were tested for antimicrobial activity against Gram positive 
[Staphylococcus aureus (MTCC3160), Bacillus cereus (MTCC6620)] & Gram negative [Escherichia coli (MTCC1650), 
Salmonella typhi (MTCC3224) and Pseudomonas aeruginosa (MTCC2453)] bacteria. Of the 15 isolates, one isolate, CBI-8, 
which showed good antimicrobial activity, was selected for further studies. The isolate was identified by MALDI-TOF & 
16S rDNA sequencing as Klebsiella variicola/quasipneumonae (strain IS93) (genebank - MN814029). To induce and 
augment the production of antimicrobial molecules, CBI-8 was grown in the presence of Salmonella typhi and the spent 
medium was subjected to ammonium sulphate precipitation. The fractions which showed promising activity were further 
subjected to preparatory HPLC. The distinct bands obtained in the SDS-PAGE corresponding to the HPLC peak that showed 
antimicrobial activity from the induced sample was analyzed by Mass Spectrometry. Antimicrobial Peptide Database 
(APD3) calculator, Collection of Anti-Microbial Peptides (CAMPR3) software used to predict AMPs in the proteins 
identified from MS data. 
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Development of resistance by the microbes to the 
antibiotics necessitated search for newer molecules1-4. 
A number of antimicrobial proteins5 lectins6 and 
peptides (AMPs) have been investigated as alternative 
to the antibiotics5. Antimicrobial proteins are part of 
the innate immune system of metazoans and for 
bacteria they are essential for competitive survival.  
Bacteriocins, the antimicrobial proteins produced by 
bacteria, are capable inhibiting growth of closely 
related bacteria of the same species as well as 
unrelated species, without harming themselves5, 7, for 
eg. Klebicins from Klebsiella sp.8.  
Bacteriocins are classified into various groups viz. 
(i) higher molecular weight colicins and lower
molecular weight microcins from Gram negative
bacteria; and (ii) class I, II and III from Gram positive
bacteria. The mechanism of action of bacteriocins
include enzyme inhibition, pore formation, prevention
of cell wall-formation, DNA/RNA/ protein/peptido-
glycan digestion, and inhibition of protein/nucleic 
acid synthesis9. Bacteriocins have been successfully 
used for food preservation10. Bacteriocins producing 
probiotic bacteria and purified bacteriocins have been 
reported to have application in combating gut, veginal 
and skin related infections11, 12. Colicin M like 
klebicin from K. varricola inhibited the growth of 
antibiotic resistant clinical isolates of Klebsiella8. 
Some bacteriocins exhibit antitumor activity13. It has 
been reported that colicin producing bacteria inhibit 
human colorectal carcinoma14, 15. 
The disadvantages of antimicrobial proteins are 
large size and susceptibility to degradation in gut. 
There is need for newer cost effective antimicrobials 
which are resistant to protease digestion and those 
that are active at broad pH and temperature ranges. 
Almost all bacterial sps produce at least one 
antimicrobial protein and most of them are yet to be 
identified11.   
Antimicrobial peptides (AMPs), with more than 
100 amino acids, are also promising alternative to 
antibiotics due to their specificity, broad spectrum 
activity and ability to act on multidrug resistant 
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strains as well as on biofilms16. They are variously 
categorized into several groups based on charge, origin, 
and activity6,9. Some AMPs are immunomodulatory and 
anticancerous17,18. Of the 5000 (approx.) antimicrobial 
peptides reported so far, only five (gramicidin, 
daptomycin, nisin, polymyxins and melittin) are in 
clinical use due to issues related to toxicity and 
pharmacokinetics19. In view of this, there is 
requirement of design, development and assessment 
of smaller peptides with desirable physicochemical 
and pharmacokinetic properties20-25. 
 
In an effort to identify newer antimicrobials, here, 
we isolated iron reducing bacteria from soil and tested 
antimicrobial activity of the culture supernatants. We 
report inhibitory activity of one the isolate to 
Salmonella typhi (MTCC3224). The bacterial 
supernatants were further subjected to ammonium 
sulphate precipitation and HPLC fractionation 
followed by mass spectroscopic analysis. The 
antimicrobial peptide regions of the identified 
proteins were predicted using APD3 & CAMPR3 
prediction tools.26-29and structure of the peptides 
predicted using PHYRE software. 
 
Material and Methods 
 
Selective isolation of bacteria 
We isolated 15 strains of bacteria from soil 
collected from two different sources. The approach 
for isolation involved the following: 
 
Collection of soil sample 
Soil samples were collected from a depth of 15 cm 
from coffee estates of (Coorg and the Talakaveri 
districts river basin) Karnataka, India 
 
Selective media and culture 
One gram of the soil sample was serially diluted 
and inoculated into ‘enrichment broth’, i.e., modified 
9KSilvermann medium: ammonium sulphate 3 g, 
potassium chloride 10 g, dipotassium hydrogen 
orthophosphate 0.50 g, magnesium sulphate 0.50 g, 
calcium nitrate 0.01 g, distilled water(DW) 700 mL, 
sulfuric acid 1.0 mL, ferrous sulphate 300 mL 
(14.34%w/V solution), pH 6.0 30. 
For selective isolation of the organisms, citrate 
broth M728 (0. 5 g each of ammonium sulphate, 
sodium nitrate, magnesium sulphate, dipotassium 
hydrogen orthophosphate , 0.2 g calcium chloride and 
10 g ferric ammonium citrate in 1000 mL of DW, pH 
adjusted to 6.8) was inoculated with the 1.0 g of soil. 
Growth was allowed at 37°C for 48-72 h. Next, 0.1 
mL of this culture was added to 20 mL of citrate agar 
medium, poured into Petri plates and incubated at 
37ºC for 48-72 h under facultative anaerobic 
conditions. The colonies were screened for both iron 
reduction and rapid growth & were sub-cultured31. 
 
Antagonistic profile of bacterial isolates 
Antagonistic profile of bacterial isolates was 
studied against Escherichia coli (MTCC1650), 
Bacillus cereus (MTCC6620), Salmonella typhi 
(MTCC3224), Pseudomonas aeruginosa 
(MTCC2453) and Staphylococcus aureus 
(MTCC3160). Well diffusion method was followed 
on a well developed uniform lawn of the pathogenic 
bacterial isolates. About 50 µL of the sample was 
introduced to the well and plates were incubated at 
37°C for 18-20 h. Diameter of inhibition zone 
exclusive of the diameter of the well (5 mm) was 
measured. Ampicillin (100 µg/mL) was used as 
standard and distilled water as negative control32-34. 
 
Protein purification 
The isolates showing antimicrobial activity were 
inoculated to citrate broth and were incubated at 37°C 
for 48-72 h under anaerobic conditions. Alternately, 
they were grown in presence of Salmonella typhi 
(kept separated in a dialysis bag) for 72-92 h. Culture 
supernatants were obtained by centrifugation at 5000 
g for 10 min and proteins were precipitated using 
different concentrations of (30, 40, 50, 60 and 70% 
saturation) ammonium sulphate35. The precipitates 
were collected by centrifugation (10,000 g for 10 
min), dialyzed against 0.1 M phosphate buffer (pH 
7.0) and were tested for antimicrobial activity.  
 
HPLC fractionation 
The proteins that were precipitated with 70% 
ammonium sulphate were lyophilized at 108°C. The 
lyophilized powder was reconstituted in DW and 
subjected to HPLC (C18 Column, Schimadzu) 
analysis. The analytical HPLC procedure was 
standardized with binary gradients: Buffer A 0.1% 
TFA in DW, Buffer B 0.1% TFA in acetonitrile. 
Preparatory HPLC was done using same buffers with 
Gradient (10% B for 5 min, 10-80% B for 10 min, 
80% B for 5 min, 80-10% B for 10 min), at 10.8 mL 
flow rate34. Peaks were collected, lyophilized and 
their antimicrobial activity was checked36.  
 
SDS-PAGE 
The HPLC fractions were analyzed in SDS PAGE 
(15% Separating gel and 7% stacking gels). Gels were 
stained with silver stain37. The gel bands were washed 




three times in distilled water and were stored in 1% 
acetic acid. These bands (Rf value 0.625) were 
subjected to the mass spectrometry (MS) analysis. 
 
Mass Spectrometry (MS) 
The MS analysis was done at NCBS-CCAMP, 
Bengaluru, using FT-ICR/Orbitrap system (in-gel 
trypsin digestion, ESI Nano-spray) & the data was 
analyzed by PEAKS 8 software.26 The proteins 
collected  from MS data were identified and were 
screened for antimicrobial peptides  using CAMPR3 
and APD3 database following the scheme127-29 
 
Results 
We selectively isolated soil bacteria of which 
fifteen were tested for antimicrobial activity (culture 
supernatants) against gram positive and gram negative 
bacteria, as well as fungal organisms. Of the tested 15 
isolates, CBI-8, identified as facultative anaerobic 
Gram negative rods, exhibited antimicrobial activity 
against Staphylococcus aureus (MTCC3160) and 
Salmonella typhi (MTCC3224). Ammonium sulphate 
(60 and 70%) precipitated and dialyzed culture 
supernatants of CBI-8 also showed activity against 
Salmonella typhi (MTCC3224) (Fig. 1 and hence, 
were taken for further fractionation in HPLC (Fig. 2). 
One of the preparatory HPLC peaks (peak 5) showed 
inhibitory activity to S. typhi. The purity of the 
samples obtained is given as supplementary data 
(Suppl. Table S1. All supplementary data are available 
only online along with the respective paper at NOPR 
repository at http://nopr.res.in) 
The protein bands that corresponded to the peak 5 
of preparatory HPLC were prominently enhanced in 
the induced sample (Fig. 3). These protein bands were 
subjected to in-gel digestion with trypsin and 
analyzed in MS. Three proteins were identified by 
Peptide mapping (Table 1) using BLASTp and MS 
Blast tools. These proteins were scanned for  
 
 
Scheme 1 — Flow Chart showing the analysis of MS data 
 
 
Fig. 1 — Inhibitory activity on Salmonella typhi: 50 µL of sample 
was added to the well and incubated for 18 h. (A)Ampicillin
(100 µg); (B): HPLC peak 5 (14.237 min); (C-F) are ammonium 
sulfate precipitates dialyzed v/s phosphate buffer. [The bacterial
culture  either induced in presence of Salmonella or uninduced), 
C-70% induced, D-70% uninduced, E-60% induced, F=60% 




Fig. 2 — Preparatory HPLC for the proteins obtained from 70%
ammonium sulphate precipitated and dialysed sample: Flow rate
10.8 mL/min, binary gradient elution: Solution A= Water: TFA 
(100:0.1), Solution B = Acetonitrile :TFA (100:0.1), Run
conditions: in gradient (B solution ranging from 10-80% for 10 
min, 80% for 5 min and 80-10% for 10 min). Peak at 14.237
minute represents peak 5 
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imicrobial amino acid stretches using CAMPR3 & 
APD3 tools (Table 2)27-29( Suppl. Fig. S1- S6 ).The 
secondary structures of the peptides were predicted 
using PEP- FOLD tool ( Table 3). 
To identify the isolate CBI-8, DNA was isolated 
and 16s rDNA sequence was amplified (Primers: 
Forward Primer AGAGTTTGATCCTGGCTCAG & 
Reverse Primer AAGGAGGTGATCCAGCCGCA) 
(Eppendorf Master Cycler, Nexus PCR Cycler) 
(Fig 4). The PCR band was sequenced and the 
obtained sequence was queried in the data base to 
confirm that the organism was Klebsiella variicola. 
Additionally, the CBI-8 isolate was reported to be 
Klebsiella variicola/quasipneumoniae, strain IS93 
(Sequence ID: >8756/8850 (IS93), in 16S RNA 
sequencing by MTCC Chandigarh (NCBI-
GENBANK, sequence Id MN814029) (Fig 5)38 and in 
MALIDI TOF Bacterial Identification by ‘Charles 
river Accugenix India’ ltd, Mumbai.  
Fig. 3 — Silver stained SDS PAGE gels. [separating gel -15%,
L5=Mol. Wt. marker, Lane 6 to 8 are culture supernatants precipitated
with ammonium sulphate and dialyzed v/s phosphate buffer, either
induced (ES) in the presence of Salmonella or uninduced (E):
L6=70%ES, L7=70%E, L8=70%ES, L9= HPLC Peak 5 of 70%ES] 
Table 1 — Peptide mapping of the Mass spectrometry data analysed by BLASTp for Klebsiella taxid (570) 
MS data search 
file name 




Accession no  
from MS data & NCBI 
Mapped peptide sequence Protein name  
27052020-AMPs-
APDs_proteins 
01 29 AP02279 1.FMGTALKI AMP Brevinin
7052020_Klebisella-
Variicola_proteins 
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Multispecies: MBL fold 
metallo-hydrolase 
[Klebsiella] 




   







Peptide sequence CAMPR3 APD3 
    SVM RF ANN DM % HP Net charge Sec. structure 





















SXE20359.1 7-26 GLFKLSTIFLAMLPALLSGL 0.919 0.761 AMP 0.944 65 +1 Alpha helix 
282-301 RGYAPIIRGIAKTNARVVIK 0.930 0.945 AMP 0.984 45 +5 Alpha helix 
283-302 GYAPIIRGIAKTNARVVIKQ 0.951 0.893 AMP 0.979 45 +4 Alpha helix 
285-304 APIIRGIAKTNARVVIKQNG 0.909 0.968  0.979 45 +4 Alpha helix 















2-21 KQRSFCPGRLSTAIAIALCC 0.895 0.6775 AMP 0.927 55 +3 Alpha helix 
3-22 QRSFCPGRLSTAIAIALCCF 0.810 0.7395 AMP 0.969 60 +2 Alpha helix 
4-23 RSFCPGRLSTAIAIALCCFP 0.944 0.886 AMP 0.989 60 +2 Alpha helix 
5-24 SFCPGRLSTAIAIALCCFPP 0.919 0.566 AMP 0.965 60 +1 Alpha helix 
6-25 FCPGRLSTAIAIALCCFPPF 0.957 0.7875 AMP 0.972 63 +1 Alpha helix 
7-26 CPGRLSTAIAIALCCFPPFS 0.923 0.7725 AMP 0.981 60 +1 Alpha helix 
8-27 PGRLSTAIAIALCCFPPFSS 0.887 0.5295 AMP 0.932 55 +1 Beta helix 
9-28 GRLSTAIAIALCCFPPFSSG 0.940 0.7375 AMP 0.975 55 +1 Beta helix 
10-29 RLSTAIAIALCCFPPFSSGQ 0.919 0.582 AMP 0.903 55 +1 Beta helix 
287-306 IRGVAQSNALVTVRQGSNII 0.935 0.731 AMP 0.945 45 +2 Alpha helix 
795-814 FISDANAKRAIVKWSGGQCS 0.824 0.926 AMP 0.910 45 +2 Alpha helix 











2-21 KLTPIVKGLALAGLLNSLAF 0.939 0.889 AMP 0.979 60 +2 Alpha helix 
3-22 LTPIVKGLALAGLLNSLAFA 0.937 0.9095 AMP 0.993 65 +1 Alpha helix 
5-24 PIVKGLALAGLLNSLAFAAS 0.9 0.664 AMP 0.994 65 +1 Alpha helix 
6-26 IVKGLALAGLLNSLAFAASA 0.98 0.9705 AMP 0.998 70 +1 Alpha helix 
4-23 TPIVKGLALAGLLNSLAFAA 0.74 0.6075 AMP 0.991 65 +1 Alpha helix 
[CAMPR3 –Collection of antimicrobial peptides; APD3- Antimicrobial peptide database; SVM-Support vector machine; RF-Random forest; ANN-




Table 3 — 3D structure of the peptides from predicted by PEP-FOLD3 software 



















































   (Contd.)




Table 3 — 3D structure of the peptides from predicted by PEP-FOLD3 software (Contd.) 


















































Fig. 4 — Agarose (2%) gels of PCR amplified 16s rDNA 
sequences (isolate CBI-8). [Lane 2- DNA ladder, Lane 3- 
Genomic DNA, Lane 4, 5, and 7 are triplicates of PCR amplified 
products displaying 1500bp (approx.)] 
 
Discussion 
In an effort to identify newer antimicrobial proteins 
and peptides from soil bacteria, we isolated 15 strains 
and tested antimicrobial activity of their culture 
supernatants.  Of the 15 strains only one isolate (CBI-
8) showed inhibitory effect on Salmonella typhi and 
Staphylococcus aureus. This organism was identified 
by MALDI-TOF as Klebsiella variicola. Analysis of 
16s rDNA sequence resulted in the identification of 
the strain as Klebsiella variicola/quasepneumonae 
strain, IS93. All the three identified proteins from the 
MS data mapped to K. variicola protein sequences. K. 
variicola organisms are known to adapt to plants, 
animals and humans39. 
 
The preparatory HPLC peaks that showed 
antimicrobial activity to S. typhi were subjected to MS 
analysis that identified the following proteins: (i) 
Fimbrial outer membrane usher protein; and (ii) MBL 
fold metallo-hydrolase. Bacterial ‘fimbrial outer 
membrane usher’ proteins are pore forming proteins 
(molecular weight 86 to 100 kDa). They are part of 
chaperone-usher system that facilitates secretion of 
the fimbrial proteins. Since the protein is a membrane 
protein, whether its metabolic / cleavage products 
showed antimicrobial need to be further 
investigated40. So far, the antimicrobials reported 
from the K. variicola sps are klebicins, whose 
molecular weight range is 25-40 kDa8 whereas, our 
proteins are 100kDa in size. 
 
The second protein identified is MBL (metallo-
beta-lactamase) fold metallo-hydrolase. This belongs 
to a large family of proteins known to have wide 
range of substrate specificity and hydrolyze beta-
lactamases, RNA and DNA41. Hence, we suppose that 
the inhibitory activity observed may be due this 
protein. The Antimicrobial peptide regions of the 




above two proteins were predicted using CAMPR3 
and APD3. 
One of the MS data identified peptide 
(FMGTALKI), mapped to Brevinin (APD3 database) 
from amphibians (FMGTALKIAANVLPAAFCKIFK 
KC, APD no. AP02279). BLASTp search in 
Klebsiella sp. with FMGTALKI, resulted in 
identification of the sequence FMGTVLAGLALKI 
(100% mapping with gap) (LysE translocase protein, 
acc.no WP_100781525.1), which is predicted to be 
antimicrobial in CAMPR3. Further sequence 
confirmation of the proteins needs to be done by PCR 
amplification and sequencing of the corresponding 
genes. Antimicrobial activity of the predicted peptides 
needs experimental verification 
 
Conclusion 
Bioassay guided purification and MS analysis of 
proteins from new isolate of Klebsiella variicola led 
to identification of two antimicrobial proteins namely 
Fimbrial outer membrane usher protein and MBL 
(metallo-beta-lactamase) fold metallo-hydrolase 
protein. The antimicrobial peptide regions of the 
above two proteins were predicted using CAMPR3 
and APD3 database. One peptide FMGTALKI was 
identified which mapped to Brevinin from 
Amphibians in APD3 database and was predicted 
antimicrobial in CAMPR3. 
Further work needs to be done for determination of 
the sequence function and the antimicrobial activity 
needs experimental validation.  
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